The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction
2002

Recurrence Patterns in Oesophago-Gastric Junction Adenocarcinoma

Sample size: 169 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wayman J, Bennett M K, Raimes S A, Griffin S M

Primary Institution: The Northern Oesophago-Gastric Cancer Unit, University of Newcastle upon Tyne

Hypothesis

The study aims to demonstrate and compare the pattern of dissemination and recurrence in patients with Type I and Type II adenocarcinoma of the oesophago-gastric junction.

Conclusion

Type I and Type II adenocarcinoma of the oesophago-gastric junction have a predominantly early, haematogenous pattern of recurrence.

Supporting Evidence

  • One hundred and three patients developed proven recurrent disease.
  • The most frequent type of recurrence was haematogenous, occurring in 56% of Type I and 54% of Type II recurrences.
  • Local recurrence occurred in 33% of Type I cancer and 29% of Type II recurrences.
  • Only 7% of Type I and 15% of Type II cancer recurrences were by peritoneal dissemination.
  • Lymph node status and histological evidence of lymphatic invasion were significant independent prognostic factors.

Takeaway

This study looked at how often and where cancer comes back in patients who had surgery for a specific type of stomach and esophagus cancer. It found that most recurrences happen early and spread through the blood.

Methodology

A prospective audit of clinico-pathological features of patients who underwent surgery for adenocarcinoma of the oesophago-gastric junction between 1991 and 1996, with follow-up through clinical examinations and imaging.

Potential Biases

The study is biased towards diagnosing symptomatic recurrence and may not accurately reflect the true recurrence rates.

Limitations

The study may underestimate the incidence of small peritoneal and local recurrences due to reliance on symptomatic recurrence detection.

Participant Demographics

The study included 169 patients, with a higher male to female ratio in Type I junctional cancer.

Statistical Information

P-Value

0.002

Confidence Interval

75.3 months (57–133)

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6600252

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication